Amyloid bodies are usually unhealthy developments, most notably in Alzheimer’s disease. Yet amyloid bodies, which are aggregates of alternatively folded proteins, may point to a new form of cancer therapy. Amyloid bodies put cells—including cancer cells—into a dormant state. Unfortunately, in cancer cells, amyloid bodies sometimes disaggregate, and the proteins that are released tend to resume their typical folds. The result: Cancer cells are reactivated. But what if disaggregation of amyloid bodies in cancer cells could be prevented? The cancer cells wouldn’t die. They would, however, stay dormant—and they would stop contributing to the progression of cancer."